Azetukalner, a Novel KV7 Potassium Channel Opener, in Adults With Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.14278
Abstract: This randomized clinical trial assesses the efficacy and safety of azetukalner, a novel, KV7 potassium channel opener, in participants with MDD. read more here.
Keywords: kv7 potassium; channel opener; novel kv7; potassium channel ... See more keywords